The University of Chicago Header Logo

Connection

Barry G. Arnason to T-Lymphocytes

This is a "connection" page, showing publications Barry G. Arnason has written about T-Lymphocytes.
Connection Strength

0.823
  1. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler. 2010 Jan; 16(1):30-8.
    View in: PubMed
    Score: 0.228
  2. Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Ann Neurol. 1990 Apr; 27(4):366-72.
    View in: PubMed
    Score: 0.058
  3. Sympathetic nervous system and PC12 pheochromocytoma-derived factors suppress stimulation of lymphocytes. Brain Behav Immun. 1990 Mar; 4(1):23-9.
    View in: PubMed
    Score: 0.058
  4. A phenotypic analysis of T lymphocytes isolated from the brains of mice with allogeneic neural transplants. Prog Brain Res. 1988; 78:249-59.
    View in: PubMed
    Score: 0.050
  5. Effect of myasthenia serum and anti-acetylcholine receptor monoclonal antibody on the distributions of T-cell subsets in myasthenia patients and normal subjects. Asian Pac J Allergy Immunol. 1985 Jun; 3(1):30-6.
    View in: PubMed
    Score: 0.042
  6. T regulator cell surface antigens in multiple sclerosis. Ann N Y Acad Sci. 1984; 436:247-53.
    View in: PubMed
    Score: 0.038
  7. Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis. Proc Natl Acad Sci U S A. 1982 May; 79(10):3330-4.
    View in: PubMed
    Score: 0.034
  8. Generation of suppressor cells by aggregated human globulin. Clin Exp Immunol. 1981 Feb; 43(2):351-6.
    View in: PubMed
    Score: 0.031
  9. Reduced T-lymphocyte cell reactivity as a function of human aging. Cell Immunol. 1980 Aug 15; 54(1):184-92.
    View in: PubMed
    Score: 0.030
  10. Suppressor cell function in man: evidence for altered sensitivity of responder cells with age. Clin Immunol Immunopathol. 1979 Jun; 13(2):119-24.
    View in: PubMed
    Score: 0.027
  11. Mitogen responsiveness and suppressor cell function in multiple sclerosis. Influence of age and disease activity. Neurology. 1978 Oct; 28(10):999-1003.
    View in: PubMed
    Score: 0.026
  12. Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology. 1978 Sep; 28(9 Pt 2):106-10.
    View in: PubMed
    Score: 0.026
  13. Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis. Trans Am Neurol Assoc. 1978; 103:191-3.
    View in: PubMed
    Score: 0.025
  14. Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis. J Autoimmun. 1996 Oct; 9(5):587-97.
    View in: PubMed
    Score: 0.023
  15. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med. 1976 Mar 25; 294(13):694-8.
    View in: PubMed
    Score: 0.022
  16. Preferential increase of IL-2R+ CD4+ T cells and CD45RB- CD4+ T cells in the central nervous system in experimental allergic encephalomyelitis. J Neuroimmunol. 1992 Jun; 38(3):255-61.
    View in: PubMed
    Score: 0.017
  17. Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol. 1987 Oct 01; 139(7):2275-83.
    View in: PubMed
    Score: 0.012
  18. Immunoregulation in multiple sclerosis. Ann N Y Acad Sci. 1984; 436:133-9.
    View in: PubMed
    Score: 0.009
  19. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol Clin. 1983 Aug; 1(3):765-82.
    View in: PubMed
    Score: 0.009
  20. The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol. 1982 Jun; 2(3-4):223-34.
    View in: PubMed
    Score: 0.008
  21. Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann Neurol. 1982 May; 11(5):456-62.
    View in: PubMed
    Score: 0.008
  22. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol. 1982 Feb; 11(2):177-81.
    View in: PubMed
    Score: 0.008
  23. Comparison between antibody-induced modulation of suppressor cells and suppressor cell changes in multiple sclerosis. Trans Am Neurol Assoc. 1981; 106:233-6.
    View in: PubMed
    Score: 0.008
  24. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol. 1979 Apr; 5(4):338-42.
    View in: PubMed
    Score: 0.007
  25. A study of B and T cells in multiple sclerosis. Neurology. 1975 May; 25(5):444-7.
    View in: PubMed
    Score: 0.005
  26. Proceedings: Immunogenetic aspects of demyelinating disease. Neurology. 1975 May; 25(5):489.
    View in: PubMed
    Score: 0.005
  27. The function of the CD2 protein is abnormal in multiple sclerosis. J Autoimmun. 1991 Jun; 4(3):479-91.
    View in: PubMed
    Score: 0.004
  28. Beta-adrenergic receptors on splenic lymphocytes from axotomized mice. Int J Immunopharmacol. 1984; 6(3):171-7.
    View in: PubMed
    Score: 0.002
  29. Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humans. Mech Ageing Dev. 1983 Sep; 23(1):11-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.